U.S. Court in South Carolina Sides with Provider in 340B “Patient” Eligibility Row
- November 10, 2023
A federal district court in South Carolina rejected November 3 the Health Resources Administration’s (HRSA’s) restrictive view of the term “patient” for purposes of the 340B discount drug program, finding the agency’s interpretation was at odds with the 340B statute’s expansive definition.
ARTICLE TAGS
You must be logged in to access this content.